Dual antiplatelet therapy after coronary drug‐eluting stent implantation in China: A large single center study

Dual antiplatelet therapy after coronary drug‐eluting stent implantation in China: A large... AbbreviationsACSacute coronary syndromeAMIacute myocardial infarctionBARCbleeding academic research consortiumCADcoronary artery diseaseCRcomplete revascularization;DAPTdual antiplatelet therapyDESdrug‐eluting stentIRincomplete revascularizationMACCEmajor adverse cardiovascular and cerebrovascular eventsMImyocardial infarctionORodds ratiosPCIpercutaneous coronary interventionSTstent thrombosisTVRtarget vessel revascularizationINTRODUCTIONDual antiplatelet therapy (DAPT), aspirin in combination with a P2Y12 antagonist, is an essential component of the treatment of patients undergoing percutaneous coronary intervention (PCI), particularly with a drug‐eluting stent (DES) . Therefore, a minimum DAPT duration of 12 months after DES implantation was recommended by guidelines, regardless of reported clinical research results . However, with the advent of new generation DESs, which are associated with a consistent reduction in stent thrombosis (ST) compared with first‐generation DESs , the optimal duration of DAPT is under debate. Although a reduced DAPT duration was considered safe and with a reduced risk of bleeding complications , ST after more than 12 months after DES implantation was observed . Thus, updated guidelines with adjusted DAPT duration after DES implantation has been recommended, according to the patients' bleeding and ischemic risks .For real clinical cases, DAPT duration after DES implantation is more complicated, determined by both physicians' comprehension of the complex guidelines and the patients' compliance . Data from the PARIS (patterns of nonadherence to antiplatelet regimens in stented http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley

Dual antiplatelet therapy after coronary drug‐eluting stent implantation in China: A large single center study

Loading next page...
 
/lp/wiley/dual-antiplatelet-therapy-after-coronary-drug-eluting-stent-0mv3E0cQdA
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27500
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsACSacute coronary syndromeAMIacute myocardial infarctionBARCbleeding academic research consortiumCADcoronary artery diseaseCRcomplete revascularization;DAPTdual antiplatelet therapyDESdrug‐eluting stentIRincomplete revascularizationMACCEmajor adverse cardiovascular and cerebrovascular eventsMImyocardial infarctionORodds ratiosPCIpercutaneous coronary interventionSTstent thrombosisTVRtarget vessel revascularizationINTRODUCTIONDual antiplatelet therapy (DAPT), aspirin in combination with a P2Y12 antagonist, is an essential component of the treatment of patients undergoing percutaneous coronary intervention (PCI), particularly with a drug‐eluting stent (DES) . Therefore, a minimum DAPT duration of 12 months after DES implantation was recommended by guidelines, regardless of reported clinical research results . However, with the advent of new generation DESs, which are associated with a consistent reduction in stent thrombosis (ST) compared with first‐generation DESs , the optimal duration of DAPT is under debate. Although a reduced DAPT duration was considered safe and with a reduced risk of bleeding complications , ST after more than 12 months after DES implantation was observed . Thus, updated guidelines with adjusted DAPT duration after DES implantation has been recommended, according to the patients' bleeding and ischemic risks .For real clinical cases, DAPT duration after DES implantation is more complicated, determined by both physicians' comprehension of the complex guidelines and the patients' compliance . Data from the PARIS (patterns of nonadherence to antiplatelet regimens in stented

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 15, 2018

Keywords: ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off